Lineage origin and transcriptional control of autoantigen-specific T-regulatory type 1 cells

Publication date

2024-07-05T08:50:29Z

2024-07-05T08:50:29Z

2023-09-25

2024-07-04T07:56:52Z

Abstract

T Regulatory type-1 (TR1) cells represent an immunosuppressive T cell subset, discovered over 25 years ago, that produces high levels of interleukin-10 (IL-10) but, unlike its FoxP3+ T regulatory (Treg) cell counterpart, does not express FoxP3 or CD25. Experimental evidence generated over the last few years has exposed a promising role for TR1 cells as targets of therapeutic intervention in immune-mediated diseases. The discovery of cell surface markers capable of distinguishing these cells from related T cell types and the application of next generation sequencing techniques to defining their transcriptional make-up have enabled a more accurate description of this T cell population. However, the developmental biology of TR1 cells has long remained elusive, in particular the identity of the cell type(s) giving rise to bona fide TR1 cells in vivo. Here, we review the fundamental phenotypic, transcriptional and functional properties of this T cell subset, and summarize recent lines of evidence shedding light into its ontogeny.

Document Type

Article


Published version

Language

English

Subjects and keywords

Cèl·lules T; Nanomedicina; T cells; Nanomedicine

Publisher

Frontiers

Related items

Reproducció del document publicat a: https://doi.org/10.3389/fimmu.2023.1267697

Frontiers In Immunology, 2023, vol. 14

https://doi.org/10.3389/fimmu.2023.1267697

Recommended citation

This citation was generated automatically.

Rights

cc by (c) Angelats Canals, Edgar et al, 2023

http://creativecommons.org/licenses/by/3.0/es/